Teriflunomide Concentrations in Cerebrospinal Fluid and Plasma in Patients with Multiple Sclerosis: A Pharmacokinetic Study
ConclusionsFurther studies are warranted to determine if the obtained CSF teriflunomide concentration reflects that in the CNS and is able to influence inflammatory and degenerative processes within the CNS.
Source: CNS Drugs - Category: Neurology Source Type: research
More News: Brain | Children | Disability | Mitochondrial Disease | Multiple Sclerosis | Neurology | Study